HeartBeam Joins EU EXIT-CVD Consortium, Will Lead HEART-CHECK Study

HeartBeam will lead HEART-CHECK, evaluating its at-home ECG system in high-risk post-ACS patients. Its contribution is in-kind, and device use for heart attack assessment is investigational.